Biohaven BHVN
NYSE BHVN
$15.69 -0.17 (-1.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Biohaven (BHVN) Short-term Investments (2022 - 2026)

Biohaven (BHVN) posted Short-term Investments of $74.7 million for Q1 2026, down 16.19% sequentially from $89.2 million in Q4 2025, and down 66.68% YoY from $224.3 million in Q1 2025.

Analysis

Biohaven (BHVN) Short-term Investments (2022 - 2026) Analysis & Trends

Biohaven has reported Short-term Investments for 5 years, with the latest figure at $74.7 million in Q1 2026.

  • Quarterly Short-term Investments fell 66.68% year-over-year to $74.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $74.7 million (down 66.68% YoY) and the FY2025 annual result came in at $89.2 million, down 76.95% from the prior year.
  • Short-term Investments declined to $74.7 million in Q1 2026 per BHVN's latest filing, from $89.2 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $386.9 million in Q4 2024 and troughed at $28000.0 in Q3 2023.
  • A 5-year average of $155.6 million and a median of $117.1 million in 2023 frame the typical range for Short-term Investments.
  • The sharpest annual moves came in 2024 and 2025: Short-term Investments surged 1051421.43% in 2024, then slumped 76.95% in 2025.
  • Over 5 years, Short-term Investments stood at $260.5 million in 2022, then tumbled by 48.78% to $133.4 million in 2023, then jumped by 189.96% to $386.9 million in 2024, then plunged by 76.95% to $89.2 million in 2025, then slipped by 16.19% to $74.7 million in 2026.
  • According to Business Quant data, Short-term Investments over the past three periods registered $74.7 million, $89.2 million, and $75.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Biohaven 2.37 Bn 2.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.83 Mn
Mar 31, 2026 74.74 Mn
Dec 31, 2025 89.18 Mn
Sep 30, 2025 75.37 Mn
Jun 30, 2025 239.18 Mn
Mar 31, 2025 224.33 Mn
Dec 31, 2024 386.86 Mn
Sep 30, 2024 294.43 Mn
Jun 30, 2024 197.80 Mn
Mar 31, 2024 100.71 Mn
Dec 31, 2023 133.42 Mn
Sep 30, 2023 128.90 Mn
Jun 30, 2023 187.50 Mn
Mar 31, 2023 263.00 Mn
Dec 31, 2022 260.46 Mn